Quantamental Technologies LLC Ligand Pharmaceuticals Inc Transaction History

Quantamental Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$80.55 - $106.05 $220,143 - $289,834	-2,733 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$89.56 - $126.72 $244,767 - $346,325	2,733 New	2,733 $261,000
Q1 2020 May 15, 2020	SELL	$63.37 - $107.88 $147,208 - $250,605	-2,323 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $225,191 - $263,869	2,323 New	2,323 $242,000
Q3 2019 Nov 08, 2019	SELL	$86.25 - $120.16 $38,467 - $53,591	-446 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$107.38 - $129.34 $47,891 - $57,685	446 New	446 $51,000
Q1 2019 Apr 29, 2019	SELL	$105.93 - $142.47 $53,070 - $71,377	-501 Closed	0 $0
Q4 2018 Jan 28, 2019	BUY	$128.36 - $272.13 $64,308 - $136,337	501 New	501 $68,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.